| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780047 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
Any postdiagnosis use of non-aspirin NSAIDs did not influence ovarian cancer mortality overall, however, more intensive use was associated with improved survival of serous ovarian cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Freija Verdoodt, Christian Dehlendorff, Søren Friis, Susanne K. Kjaer,